#USA #Denver #Healthcare Conference #Investor Relations #DaVita Inc.

DaVita Inc. at the Barclays Global Healthcare Conference 2025

DaVita Inc. (NYSE: DVA) is gearing up to take part in the prestigious Barclays Global Healthcare Conference, a vital event for investors seeking insights into the healthcare sector. Scheduled for March 11, 2025, the conference will feature a fireside chat with key executives from DaVita, including Chief Financial Officer Joel Ackerman and Group Vice President of Investor Relations Nic Eliason. The discussion is set to kick off at 9:00 AM EDT, providing a unique opportunity for investors to engage with DaVita's leadership and gain a deeper understanding of the company’s strategies and vision.

Registered attendees can tune in to the event via the Barclays conference page, which will host a live webcast following the necessary registration process. This participation indicates DaVita’s commitment to transparency and investor relations, showcasing its ongoing efforts to foster strong ties with the investment community.

About DaVita Inc.

Founded over two decades ago, DaVita has established itself as a leader in the kidney care industry. The company not only concentrates on dialysis but also emphasizes transforming the overall delivery of healthcare to enhance the quality of life for its patients worldwide. With its comprehensive approach to kidney care, DaVita supports patients through various stages of their kidney health journey—from delaying the onset of kidney disease to facilitating successful transplants.

As of December 31, 2024, DaVita was serving approximately 281,100 patients across its network of 3,166 outpatient dialysis centers. This includes 2,657 facilities in the United States and 509 in various countries around the globe. The company has consistently achieved remarkable results, such as reducing hospitalization rates, improving patient mortality, and enhancing health access. DaVita’s dedication to collaborative initiatives has significantly contributed to elevating the quality standards in kidney care across the industry.

For interested parties wishing to learn more about DaVita’s involvement at the conference or about the company itself, further information can be found on the DaVita website under the 'About' section. The corporate commitment to patient-centered care and community engagement sets DaVita apart in the healthcare landscape, solidifying its reputation as a frontrunner in clinical excellence and patient satisfaction.

In wrapping up its preparations, DaVita remains enthusiastic about its participation in Barclays Global Healthcare Conference 2025. The insights shared during this event are anticipated to provide invaluable guidance for current and potential investors navigating the evolving healthcare market landscape. As DaVita continues to innovate and improve care delivery, the firm invites all stakeholders to engage deeply with their mission—enhancing lives through comprehensive kidney care services worldwide.